Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.

OBJECTIVE The objective of our study was to compare T2-weighted MRI alone and T2 combined with diffusion-weighted imaging (DWI) for the localization of prostate cancer. SUBJECTS AND METHODS T2-weighted imaging and DWI (b value = 600 s/mm2) were performed in 49 patients before radical prostatectomy using an endorectal coil at 1.5 T in this prospective trial. The peripheral zone of the prostate was divided into sextants and the transition zone into left and right halves. T2 images alone and then T2 images combined with apparent diffusion coefficient (ADC) maps (T2 + DWI) were scored for the likelihood of tumor and were compared with whole-mount histology results. Fixed window and level settings were used to display the ADC maps. Only tumors with an area of more than 0.13 cm2 (> 4 mm diameter) and a Gleason score of > or = 6 were considered significant. The area under the receiver operating characteristic curve (A(z)) was used to assess accuracy. RESULTS In the peripheral zone, the A(z) value was significantly higher (p = 0.004) for T2 plus DWI (A(z) = 0.89) than for T2 imaging alone (A(z) = 0.81). Performance was poorer in the transition zone for both T2 plus DWI (A(z) = 0.78) and T2 (A(z) = 0.79). For the whole prostate, sensitivity was significantly higher (p < 0.001) with T2 plus DWI (81% [120/149]) than with T2 imaging alone (54% [81/149]), with T2 plus DWI showing only a slight loss in specificity compared with T2 imaging alone (84% [204/243] vs 91% [222/243], respectively). CONCLUSION Combined T2 and DWI MRI is better than T2 imaging alone in the detection of significant cancer (Gleason score > or = 6 and diameter > 4 mm) within the peripheral zone of the prostate.

[1]  H. Hricak,et al.  Prostate cancer imaging , 2008, Acta radiologica.

[2]  Silvia D. Chang,et al.  Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.

[3]  Thomas Hambrock,et al.  Diffusion and perfusion MR imaging of the prostate. , 2008, Magnetic resonance imaging clinics of North America.

[4]  T. Stamey,et al.  The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. , 1994, The Journal of urology.

[5]  K. Macura.  Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging. , 2008, Seminars in roentgenology.

[6]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[7]  A W Partin,et al.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.

[8]  H. Hricak,et al.  Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.

[9]  J A Hanley,et al.  Extension of receiver operating characteristic analysis to data concerning multiple signal detection tasks. , 1997, Academic radiology.

[10]  Gary Liney,et al.  Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.

[11]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[12]  W Leisenring,et al.  A marginal regression modelling framework for evaluating medical diagnostic tests. , 1997, Statistics in medicine.

[13]  Thomas Hambrock,et al.  Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative Radiology.

[14]  K. Hosseinzadeh,et al.  Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.

[15]  J. Fütterer,et al.  Imaging the male reproductive tract: current trends and future directions. , 2008, Radiologic clinics of North America.

[16]  L. Fass.  Imaging and cancer: A review , 2008, Molecular oncology.

[17]  Béla Ágai,et al.  CONDENSED 1,3,5-TRIAZEPINES - V THE SYNTHESIS OF PYRAZOLO [1,5-a] [1,3,5]-BENZOTRIAZEPINES , 1983 .

[18]  Nacim Betrouni,et al.  Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results , 2008, International Journal of Computer Assisted Radiology and Surgery.

[19]  M. Kattan,et al.  Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.

[20]  M. Rifkin,et al.  MR imaging characteristics of noncancerous lesions of the prostate , 1992, Journal of magnetic resonance imaging : JMRI.

[21]  N. Blumstein,et al.  Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. , 2008, Radiology.

[22]  P. Scardino,et al.  Is tumor volume an independent prognostic factor in clinically localized prostate cancer? , 2004, The Journal of urology.

[23]  C. Metz,et al.  Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. , 1998, Statistics in medicine.

[24]  Deanna L Langer,et al.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.

[25]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[26]  C. Kim,et al.  Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.

[27]  A. Partin,et al.  Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. , 1989, The Journal of urology.

[28]  William Wells,et al.  Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.

[29]  Xavier Leroy,et al.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.

[30]  A. Schned,et al.  Tissue-shrinkage correction factor in the calculation of prostate cancer volume. , 1996, The American journal of surgical pathology.

[31]  P. Carroll,et al.  Focal therapy for prostate cancer 1996: maximizing outcome. , 1997, Urology.

[32]  Kyung Ah Kim,et al.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.

[33]  A. D'Amico,et al.  Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study. , 2000, Urology.

[34]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[35]  B. K. Park,et al.  Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative Radiology.

[36]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.